Skip to main content
. 2008 Jul;31(7):1349–1354. doi: 10.2337/dc07-1707

Table 2—

Characteristics of the population at baseline (diabetes only)

No retinopathy Incident retinopathy P value
n 287 25
Age (years) 60 ± 11 63 ± 10 0.175
Male sex (%) 53 60 0.499
FPG (mmol/l) 7.6 ± 1.9 10.8 ± 3.8 <0.001
2-h plasma glucose (mmol/l)* 12.4 ± 3.6 16.2 ± 6.9 0.006
A1C (%) 6.3 ± 1.2 8.5 ± 1.9 <0.001
C-peptide (ng/ml) 3.9 ± 1.7 2.9 ± 1.8 0.007
Known diabetes (%) 43 80 0.001
Duration of diabetes (years) 0 (0–3) 5 (2–9) <0.001
Taking insulin or tablets (%) 57 90 0.007
BMI (kg/m2) 30.4 ± 5.9 29.1 ± 6.1 0.296
Waist circumference (cm) 101.4 ± 13.7 98.8 ± 12.9 0.366
Albumin-to-creatinine ratio (mg/mmol) 0.8 (0.5–1.6) 1.2 (0.5–4.5) 0.115
Lipid treatment (%) 26 28 0.001
HDL cholesterol (mmol/l) 1.2 ± 0.3 1.2 ± 0.4 0.971
Total cholesterol (mmol/l) 5.7 ± 1.0 5.2 ± 0.9 0.026
Triglycerides (mmol/l) 1.9 (1.3–2.8) 1.7 (0.8–2.6) 0.189
Current smoker (%) 10 4 0.334
Hypertension (%) 40 40 0.313
SBP (mmHg) 142 ± 18 152 ± 23 0.005
DBP (mmHg) 75 ± 12 78 ± 14 0.334

Data are means ± SD or median (interquartile range).

*

Those with KDM and on current treatment with tablets or insulin did not undergo an oral glucose tolerance test.

Newly diagnosed participants given duration of zero. DBP, diastolic blood pressure; SBP, systolic blood pressure.